Trial Profile
Differences in metabolic and cardiovascular effects of pioglitazone vs. insulin glargine in the treatment of secondary drug failure in type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Mar 2008 New trial record.